Clinical Inertia in Individualising Care for Diabetes: Is There Time to do More in Type 2 Diabetes?

Diabetes Therapy

Volumn 5, Issue 2, 2014, Pages 347-354

  Strain, William David ^a   Blüher, Matthias ^b   Paldánius, Païvi ^c  

^a UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; METFORMIN; PLACEBO; SULFONYLUREA;

CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); DOCTOR PATIENT RELATION; EDUCATION; GLYCEMIC CONTROL; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH INSURANCE; HUMAN; HYPOGLYCEMIA; INSULIN TREATMENT; LIFESTYLE MODIFICATION; MOTIVATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; PATIENT CARE; PHYSICIAN; PLACEBO EFFECT; PREVALENCE;

EID: 84919631887     PISSN: 18696953     EISSN: 18696961     Source Type: Journal    
DOI: 10.1007/s13300-014-0077-8     Document Type: Note

References (15)

1. Nichols GA, Koo YH, Shah SN. Delay of insulin addition to oral combination therapy despite inadequate glycemic control: delay of insulin therapy. J Gen Intern Med. 2007;22(4):453–8 (PubMed PMID: 17372792, Pubmed Central PMCID: 1829438).
2. Khunti K, Wolden ML, Thorsted BL, Andersen M, Davies MJ. Clinical inertia in people with type 2 diabetes: a retrospective cohort study of more than 80,000 people. Diabetes Care. 2013;36(11):3411–7 (PubMed PMID: 23877982, Pubmed Central PMCID: 3816889).
3. Home P, Naggar NE, Khamseh M, Gonzalez-Galvez G, Shen C, Chakkarwar P, et al. An observational non-interventional study of people with diabetes beginning or changed to insulin analogue therapy in non-Western countries: the A1chieve study. Diabetes Res Clin Pract. 2011;94(3):352–63 (PubMed PMID: 22153567).
4. Hoerger TJ, Segel JE, Gregg EW, Saaddine JB. Is glycemic control improving in US adults? Diabetes Care. 2008;31(1):81–6 (PubMed PMID: 17934153).
5. Braga M, Casanova A, Teoh H, Dawson KC, Gerstein HC, Fitchett DH, et al. Treatment gaps in the management of cardiovascular risk factors in patients with type 2 diabetes in Canada. The Canadian journal of cardiology. 2010;26(6):297–302 (PubMed PMID: 20548975, Pubmed Central PMCID: 2903985).
6. Yoshioka N, Ishii H, Tajima N, Iwamoto Y, Group DJ. Differences in physician and patient perceptions about insulin therapy for management of type 2 diabetes: the DAWN Japan study. Curr Med Res Opin. 2014;30(2):177–83 (PubMed PMID: 24128339).
7. Lovshin JA, Zinman B. Diabetes: clinical inertia—a barrier to effective management of T2DM. Nat Rev Endocrinol. 2013;9(11):635–6 (PubMed PMID: 24042326).
8. Stark Casagrande S, Fradkin JE, Saydah SH, Rust KF, Cowie CC. The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988–2010. Diabetes Care. 2013;36(8):2271–9 (PubMed PMID: 23418368, Pubmed Central PMCID: 3714503).
9. Strain WD, Lukashevich V, Kothny W, Hoellinger MJ, Paldanius PM. Individualised treatment targets for elderly patients with type 2 diabetes using vildagliptin add-on or lone therapy (INTERVAL): a 24 week, randomised, double-blind, placebo-controlled study. Lancet. 2013;382(9890):409–16 (PubMed PMID: 23706759).
10. Parchman ML, Pugh JA, Romero RL, Bowers KW. Competing demands or clinical inertia: the case of elevated glycosylated hemoglobin. Annals of family medicine. 2007;5(3):196–201 (PubMed PMID: 17548846, Pubmed Central PMCID: 1886492).
11. Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care. 2004;27(5):1218–24 (PubMed PMID: 15111553).
12. Franco M, Bilal U, Ordunez P, Benet M, Morejon A, Caballero B, et al. Population-wide weight loss and regain in relation to diabetes burden and cardiovascular mortality in Cuba 1980–2010: repeated cross sectional surveys and ecological comparison of secular trends. BMJ. 2013;346:f1515 (PubMed PMID: 23571838).
13. Handelsman Y, Jellinger PS. Overcoming obstacles in risk factor management in type 2 diabetes mellitus. J Clin Hypertens (Greenwich). 2011;13(8):613–20 (PubMed PMID: 21806772).
14. Broadbent E, Donkin L, Stroh JC. Illness and treatment perceptions are associated with adherence to medications, diet, and exercise in diabetic patients. Diabetes Care. 2011;34(2):338–40 (PubMed PMID: 21270191, Pubmed Central PMCID: 3024345).
15. Garcia-Perez LE, Alvarez M, Dilla T, Gil-Guillen V, Orozco-Beltran D. Adherence to therapies in patients with type 2 diabetes. Diabetes therapy: research, treatment and education of diabetes and related disorders. 2013;4(2):175–94 (PubMed PMID: 23990497, Pubmed Central PMCID: 3889324).